| Product Code: ETC9680611 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Cardiac Biomarkers Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Cardiac Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Cardiac Biomarkers Market - Industry Life Cycle |
3.4 Thailand Cardiac Biomarkers Market - Porter's Five Forces |
3.5 Thailand Cardiac Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Cardiac Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand Cardiac Biomarkers Market Revenues & Volume Share, By Location of Testing, 2021 & 2031F |
4 Thailand Cardiac Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Thailand |
4.2.2 Rising awareness about early diagnosis and treatment of heart conditions |
4.2.3 Technological advancements in cardiac biomarker testing |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure in certain regions of Thailand |
4.3.2 High cost associated with cardiac biomarker tests |
4.3.3 Lack of skilled healthcare professionals specializing in cardiac biomarkers |
5 Thailand Cardiac Biomarkers Market Trends |
6 Thailand Cardiac Biomarkers Market, By Types |
6.1 Thailand Cardiac Biomarkers Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Cardiac Biomarkers Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Cardiac Biomarkers Market Revenues & Volume, By Myocardial muscle Creatine Kinase (CK-MB), 2021- 2031F |
6.1.4 Thailand Cardiac Biomarkers Market Revenues & Volume, By Troponins (T and I), 2021- 2031F |
6.1.5 Thailand Cardiac Biomarkers Market Revenues & Volume, By Myoglobin, 2021- 2031F |
6.1.6 Thailand Cardiac Biomarkers Market Revenues & Volume, By Brain Natriuretic Peptide (BNPs) or NT-proBNP, 2021- 2031F |
6.1.7 Thailand Cardiac Biomarkers Market Revenues & Volume, By Ischemia Modified Albumin (IMA), 2021- 2031F |
6.1.8 Thailand Cardiac Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Cardiac Biomarkers Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Cardiac Biomarkers Market Revenues & Volume, By Myocardial Infarction, 2021- 2031F |
6.2.3 Thailand Cardiac Biomarkers Market Revenues & Volume, By Congestive Heart Failure, 2021- 2031F |
6.2.4 Thailand Cardiac Biomarkers Market Revenues & Volume, By Acute Coronary Syndrome, 2021- 2031F |
6.2.5 Thailand Cardiac Biomarkers Market Revenues & Volume, By Atherosclerosis, 2021- 2031F |
6.2.6 Thailand Cardiac Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Cardiac Biomarkers Market, By Location of Testing |
6.3.1 Overview and Analysis |
6.3.2 Thailand Cardiac Biomarkers Market Revenues & Volume, By Point of care testing, 2021- 2031F |
6.3.3 Thailand Cardiac Biomarkers Market Revenues & Volume, By Laboratory testing, 2021- 2031F |
7 Thailand Cardiac Biomarkers Market Import-Export Trade Statistics |
7.1 Thailand Cardiac Biomarkers Market Export to Major Countries |
7.2 Thailand Cardiac Biomarkers Market Imports from Major Countries |
8 Thailand Cardiac Biomarkers Market Key Performance Indicators |
8.1 Adoption rate of cardiac biomarker testing technologies in Thailand |
8.2 Number of partnerships between healthcare providers and diagnostic companies for cardiac biomarker testing |
8.3 Percentage increase in the use of cardiac biomarkers for early detection and monitoring of cardiac diseases |
9 Thailand Cardiac Biomarkers Market - Opportunity Assessment |
9.1 Thailand Cardiac Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Cardiac Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand Cardiac Biomarkers Market Opportunity Assessment, By Location of Testing, 2021 & 2031F |
10 Thailand Cardiac Biomarkers Market - Competitive Landscape |
10.1 Thailand Cardiac Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Thailand Cardiac Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here